AI identifies patients with heart failure that respond to beta-blocker treatment
Researchers at BHP founder-member the University of Birmingham have developed a new way to identify which patients with heart failure will benefit from treatment with beta-blockers.
Heart failur…
Birmingham Health Partners plays key role in report calling for Government reform of regulation of medical devices
Experts within Birmingham Health Partners (BHP) have significantly contributed to a new independent report calling on the UK Government to reform the regulation of medical devices.
Lessons learn…
New Birmingham-Roche collaboration targets new treatments for inflammatory bowel disease
A new £850k collaboration between Birmingham Health Partners (BHP) and global biotechnology leaders Roche is set to improve both diagnosis and care of patients with inflammatory bowel disease (IBD)…
World-first trial to assess ‘life-extending’ cannabis-based drug for thousands with aggressive brain tumours
BHP founder member the University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
The …
Rheumatology Research Group awarded five year EULAR Centre of Excellence Status
The Rheumatology Research Group (RRG) at BHP founder-member the University of Birmingham has been awarded five-year EULAR Centre of Excellence status for the second time in a row.
EULAR (European …
New study aims to improve healthcare for pregnant women with multiple health conditions
BHP founder-member the University of Birmingham is leading a new three-year UK-wide study aimed at improving healthcare and outcomes for pregnant women who have two or more active long-term health …